The global Psoriatic Arthritis (PsA) treatment market is set for substantial expansion, with an estimated valuation of USD 11,973.7 million in 2024. This surge in market size reflects the growing need for effective treatments as the prevalence of psoriasis and its associated complications increase. Morning stiffness, nail pitting, and other symptoms drive the demand for …
Tag Archives: Psoriatic Arthritis (PsA) Treatment Market
Global Psoriatic Arthritis (PsA) Treatment Market to achieve a remarkable US$ 15.6 Billion by 2028, fueled by advancements and patient-focused approaches | FMI
The global psoriatic arthritis (PsA) treatment market is poised for significant expansion, with Future Market Insights, a leading pharmaceutical entity, at the forefront of innovation. According to recent projections, the PsA treatment industry, valued at over US$ 10.3 billion in 2022, is expected to soar to US$ 15.6 billion by 2028, representing a robust compound …
Psoriatic Arthritis Treatment Market to Achieve US$ 15.6 Billion by 2028, Powered by Innovation and Patient-Focused Care | FMI
In recent years, the psoriatic arthritis (PsA) treatment market has seen tremendous expansion and innovation, driven by developments in medical research and a rising consciousness of psoriatic arthritis among patients and healthcare professionals. Psoriatic arthritis is a long-term autoimmune disorder that damages joints and causes inflammation in people who have psoriasis. New medicines that focus …
Psoriatic Arthritis Treatment Market is projected to total US$ 15.6 Billion by 2028 Evolution: Balancing Science and Patient-Centered Approaches | FMI
The Psoriatic Arthritis (PsA) Treatment Market has been experiencing significant growth and innovation in recent years, driven by advances in medical research and a growing awareness of psoriatic arthritis among healthcare providers and patients. Psoriatic arthritis is a chronic autoimmune condition that affects individuals with psoriasis, causing inflammation, pain, and joint damage. The market for …
Psoriatic Arthritis (PsA) Treatment Market is likely to register CAGR of 7.1% through 2028
The global Psoriatic Arthritis (PsA) Treatment Market Size is anticipated to approach US$ 10.3 billion by 2022. The market is estimated to reach US$ 15.6 billion by 2028, with a 7.1% CAGR. The Psoriatic Arthritis (PsA) Treatment Market is expected to develop at a 7.1% CAGR between 2022 and 2028, up from a 6.7% CAGR …
Psoriatic Arthritis (PsA) Treatment Market size is projected to total US$ 15.6 Bn by 2028
Sales in the global Psoriatic Arthritis (PsA) Treatment Market are slated to top US$ 10.3 Bn in 2022. Expanding at a healthy 7.1% CAGR, the market size is projected to total US$ 15.6 Bn by 2028. Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-2718 The Psoriatic Arthritis (PsA) Treatment Market is expected to register 7.1% CAGR between 2022 and 2028, up from 6.7% CAGR recorded during 2013-2021, …
Psoriatic Arthritis (Psa) Treatment Market Growing at a Healthy 7.1% CAGR, and Projected a Valuation of US$ 15.6 Billion By 2028
Sustained adoption of conventional disease modifying anti-rheumatic drugs (DMARDs), especially in cost sensitive regions, is projected to push the demand for psoriatic arthritis treatment in coming years. Nearly 70% of the psoriasis patient population is prone to psoriatic arthritis, and up to 20% of arthritis patients are susceptible to acquire psoriasis, according to the recent findings of …